| Open Document File Size: 4,24 MBShare Result on Facebook
Company Cytosol Laboratories Inc. / Alcon Inc. / / Country United States / / Event FDA Phase / Product Recall / Product Issues / / Facility Laboratory Findings / / IndustryTerm salt intraocular irrigating solution / intraocular irrigating solutions / drug product / mL solution / sterile intraocular irrigating solution / ophthalmic irrigating solutions / intraocular irrigating solution / ophthalmic intraocular irrigating solutions / salt ophthalmic solution / / MedicalCondition extracapsular cataract / Toxic Anterior Segment Syndrome / pediatric cataracts / macular edema / postoperative inflammatory reactions / epiretinal membrane / hyperemia / tissue injury / irreversible eye injury / corneal edema / patients undergoing cataract / cataract / / MedicalTreatment surgeries / surgery / cataract surgery / / Organization U.S. Food and Drug Administration / FDA / Advisory Committee / / Person Indication / William M. Boyd / / Position operating surgeon / surgeon / / Product potassium chloride / Overdose / balanced salt / Endosol Extra / sodium chloride / calcium chloride / BSS Plus / BSS / sodium bicarbonate / dextrose / Original Navstel Intraocular Irrigating Solution / BSS Sterile Irrigating Solution / Original / Endosol Extra Irrigating Solution / intraocular / BSS PLUS Sterile Intraocular Irrigating Solution / C-04-18 / /
SocialTag |
22193 Navstel Clinical PREA